Purity: 98%
A novel and potent imidazo[4,5-c] quinolone derivative (NVP-BEZ235), which has entered phase I/II clinical trials in patients with advanced solid tumors, has a potential role in cisplatin-sensitive cancers by dual targeting of the PI3-K (phosphatidylinositol 3-kinase) and mTOR (mammalian target of rapamycin) kinases for NPC treatment
In silico screening-based discovery of novel inhibitors of human cyclic GMP-AMP synthase: a cross- validation study of molecular docking and experimental testing
Were all living with some level of mold
To view a copy of this licence, visit About this article Cite this article Yang, X., Yin, W., Xu, M
Aunapuu M, Kibur P, Jarveots T, Arend A (2018) Changes in morphology and presence of Pinopodes in endometrial cells during the luteal phase in women with infertility problems: A pilot study, medicina (Kaunas)